Janus Henderson Group
APLS

Janus Henderson Group’s Apellis Pharmaceuticals APLS Stock Holding History

Janus Henderson Group’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.1M Buy
252,130
+21,810
+9% +$470K ﹤0.01% 762
2025
Q4 		$5.79M Buy
230,320
+195,908
+569% +$4.6M ﹤0.01% 885
2025
Q3 		$779K Hold
34,412
– – ﹤0.01% 1786
2025
Q2 		$595K Hold
34,412
– – ﹤0.01% 1855
2025
Q1 		$836K Hold
34,412
– – ﹤0.01% 1717
2024
Q4 		$1.1M Hold
34,412
– – ﹤0.01% 1642
2024
Q3 		$992K Hold
34,412
– – ﹤0.01% 1670
2024
Q2 		$1.32M Sell
34,412
-527
-2% -$23.9K ﹤0.01% 1470
2024
Q1 		$2.05M Sell
34,939
-2,978
-8% -$190K ﹤0.01% 1283
2023
Q4 		$2.27M Sell
37,917
-74
-0.2% -$3.75K ﹤0.01% 1176
2023
Q3 		$1.44M Sell
37,991
-1,738,914
-98% -$76.4M ﹤0.01% 1356
2023
Q2 		$162M Sell
1,776,905
-2,904,577
-62% -$251M 0.1% 193
2023
Q1 		$309M Buy
4,681,482
+693,737
+17% +$40M 0.2% 120
2022
Q4 		$206M Buy
3,987,745
+3,959,473
+14,005% +$210M 0.15% 155
2022
Q3 		$1.93M Buy
28,272
+12,178
+76% +$721K ﹤0.01% 1319
2022
Q2 		$728K Buy
16,094
+122
+0.8% +$5.56K ﹤0.01% 1533
2022
Q1 		$811K Buy
15,972
+65
+0.4% +$2.87K ﹤0.01% 1613
2021
Q4 		$753K Buy
15,907
+9,814
+161% +$386K ﹤0.01% 1645
2021
Q3 		$201K Buy
+6,093
New +$342K ﹤0.01% 2077

Other funds holding APLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Janus Henderson Group's APLS Position: Q1 2026 in Review

Janus Henderson Group increased its Apellis Pharmaceuticals (APLS) stake by 9.5% in Q1 2026, buying an estimated $470K and bringing the position to 252,130 shares worth $10.1M. The position accounts for ﹤0.01% of the portfolio, ranked #762.

Janus Henderson Group first reported a position in APLS in Q3 2021 and has held it in 19 quarters since. The position peaked at $309M in Q1 2023. 323 funds tracked by Wall St. Rank hold APLS as of Q1 2026.

  • Janus Henderson Group held 252,130 shares of Apellis Pharmaceuticals worth $10.1M as of Q1 2026.
  • Janus Henderson Group bought 21,810 Apellis Pharmaceuticals shares in Q1 2026, an estimated $470K.
  • Apellis Pharmaceuticals made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #762 holding.
  • Janus Henderson Group first reported a position in Apellis Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • Janus Henderson Group's Apellis Pharmaceuticals position peaked at $309M in Q1 2023.
  • 323 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.